3/26
05:00 pm
cing
Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
Medium
Report
Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
3/6
08:12 am
cing
Cingulate Inc. (NASDAQ: CING) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Cingulate Inc. (NASDAQ: CING) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
3/4
09:08 am
cing
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025 [Yahoo! Finance]
Medium
Report
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025 [Yahoo! Finance]
3/4
09:00 am
cing
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025
High
Report
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025
1/30
08:18 am
cing
Cingulate Inc. (NASDAQ: CING) had its price target raised by analysts at HC Wainwright from $8.00 to $20.00. They now have a "buy" rating on the stock.
Medium
Report
Cingulate Inc. (NASDAQ: CING) had its price target raised by analysts at HC Wainwright from $8.00 to $20.00. They now have a "buy" rating on the stock.
1/11
05:37 am
cing
Cingulate Inc. (NASDAQ: CING) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Neutral
Report
Cingulate Inc. (NASDAQ: CING) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
1/10
08:03 am
cing
Cingulate Inc. (NASDAQ: CING) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $12.00 price target on the stock.
High
Report
Cingulate Inc. (NASDAQ: CING) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $12.00 price target on the stock.
1/7
08:35 am
cing
Final Study Completed for Cingulate's Lead Asset CTx-1301 [Yahoo! Finance]
High
Report
Final Study Completed for Cingulate's Lead Asset CTx-1301 [Yahoo! Finance]
1/7
07:30 am
cing
Final Study Completed for Cingulate’s Lead Asset CTx-1301
Medium
Report
Final Study Completed for Cingulate’s Lead Asset CTx-1301